These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 23040110

  • 1. Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy.
    Boehmer JP, Starling RC, Cooper LT, Torre-Amione G, Wittstein I, Dec GW, Markham DW, Zucker MJ, Gorcsan J, McTiernan C, Kip K, McNamara DM, IMAC Investigators.
    J Card Fail; 2012 Oct; 18(10):755-61. PubMed ID: 23040110
    [Abstract] [Full Text] [Related]

  • 2. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes.
    Simon MA, Kormos RL, Murali S, Nair P, Heffernan M, Gorcsan J, Winowich S, McNamara DM.
    Circulation; 2005 Aug 30; 112(9 Suppl):I32-6. PubMed ID: 16159839
    [Abstract] [Full Text] [Related]

  • 3. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support.
    Goldstein DJ, Maybaum S, MacGillivray TE, Moore SA, Bogaev R, Farrar DJ, Frazier OH, HeartMate II Clinical Investigators.
    J Card Fail; 2012 May 30; 18(5):392-5. PubMed ID: 22555270
    [Abstract] [Full Text] [Related]

  • 4. Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device.
    Segura AM, Radovancevic R, Demirozu ZT, Frazier OH, Buja LM.
    Cardiovasc Pathol; 2014 May 30; 23(1):17-20. PubMed ID: 23928368
    [Abstract] [Full Text] [Related]

  • 5. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yamauchi T, Kuratani T, Sawa Y.
    J Heart Lung Transplant; 2010 Jun 30; 29(6):672-9. PubMed ID: 20188595
    [Abstract] [Full Text] [Related]

  • 6. Myocardial size and fibrosis changes during left ventricular assist device support.
    Yamada Y, Saito S, Nishinaka T, Yamazaki K.
    ASAIO J; 2012 Jun 30; 58(4):402-6. PubMed ID: 22739784
    [Abstract] [Full Text] [Related]

  • 7. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
    Thompson LO, Skrabal CA, Loebe M, Lafuente JA, Roberts RR, Akgul A, Jones V, Bruckner BA, Thohan V, Noon GP, Youker KA.
    J Surg Res; 2005 Jan 30; 123(1):25-32. PubMed ID: 15652947
    [Abstract] [Full Text] [Related]

  • 8. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.
    Ann Thorac Surg; 2008 Oct 30; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Explantation of INCOR left ventricular assist device after myocardial recovery.
    Komoda T, Komoda S, Dandel M, Weng Y, Hetzer R.
    J Card Surg; 2008 Oct 30; 23(6):642-7. PubMed ID: 19016989
    [Abstract] [Full Text] [Related]

  • 11. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R, Müller JH, Weng YG, Loebe M, Wallukat G.
    J Thorac Cardiovasc Surg; 2000 Nov 30; 120(5):843-53. PubMed ID: 11044309
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
    Matsumiya G, Monta O, Fukushima N, Sawa Y, Funatsu T, Toda K, Matsuda H.
    J Thorac Cardiovasc Surg; 2005 Sep 30; 130(3):699-704. PubMed ID: 16153916
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of Myocardial Fibrosis by Left Ventricular Assist Device Apical Core Biopsy and Correlation with Other Markers of Myocardial Recovery.
    Schultz J, John R, Martin C, Kamdar F, Thenappan T, Cogswell R.
    ASAIO J; 2019 Feb 30; 65(2):123-126. PubMed ID: 29533251
    [Abstract] [Full Text] [Related]

  • 16. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S, Foronjy RF, Dickstein ML, Gu A, Garrelds IM, Danser AH, Oz MC, D'Armiento J, Burkhoff D.
    Circulation; 2005 Jul 19; 112(3):364-74. PubMed ID: 15998679
    [Abstract] [Full Text] [Related]

  • 17. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
    Klotz S, Naka Y, Oz MC, Burkhoff D.
    J Heart Lung Transplant; 2005 Sep 19; 24(9):1195-201. PubMed ID: 16143233
    [Abstract] [Full Text] [Related]

  • 18. Cardiac Recovery During Long-Term Left Ventricular Assist Device Support.
    Wever-Pinzon O, Drakos SG, McKellar SH, Horne BD, Caine WT, Kfoury AG, Li DY, Fang JC, Stehlik J, Selzman CH.
    J Am Coll Cardiol; 2016 Oct 04; 68(14):1540-53. PubMed ID: 27687196
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ.
    Circulation; 1994 Nov 04; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.